Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A benign, malignant, or borderline circumscribed biphasic neoplasm that arises from the breast. It usually affects middle-aged women. It is characterized by the presence of a double layer of epithelial cells that are arranged in clefts, surrounded by a spindle cell mesenchymal (stromal) component.
Biomarker and diagnostic research for breast phyllodes tumor has been reported in the published literature.
2 clinical trials registered. Interventions under study include other interventions and gene therapy. Pipeline includes 1 PHASE1. Research is primarily sponsored by academic and government institutions.
151 publications have been identified in PubMed for breast phyllodes tumor. Research spans Case Report / Case Series (31%), Review / Meta-Analysis (16%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 47 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 5:52 AM UTC
Research summaries | 24 | 16% |
Laboratory research | 23 | 15% |
Testing and diagnosis research | 20 | 13% |
Disease patterns and progression | 18 | 12% |
Clinical study results | 17 | 11% |
New treatment approaches | 2 | 1% |
Hosseinpour R (2026). [PMID: 42253653](https://pubmed.ncbi.nlm.nih.gov/42253653/). *Int J Surg Case Rep*. [Case Report / Case Series]
Tsukiyama E (2026). [PMID: 42078310](https://pubmed.ncbi.nlm.nih.gov/42078310/). *Cancer Diagn Progn*. [Clinical Trial Publication]
Cai L (2026). [PMID: 41746333](https://pubmed.ncbi.nlm.nih.gov/41746333/). *Virchows Archiv : an international journal of pathology*. [Epidemiology / Natural History]
Holt L (2026). [PMID: 41772243](https://pubmed.ncbi.nlm.nih.gov/41772243/). *Ann Surg Oncol*. [Epidemiology / Natural History]
Zhang J (2026). [PMID: 41810926](https://pubmed.ncbi.nlm.nih.gov/41810926/). *Fetal Pediatr Pathol*. [Basic Science / Preclinical]
Paliwal P (2026). [PMID: 42231815](https://pubmed.ncbi.nlm.nih.gov/42231815/). *Int J Surg Pathol*. [Diagnostic / Biomarker]
Gu TQ (2026). [PMID: 41918235](https://pubmed.ncbi.nlm.nih.gov/41918235/). *Clin Transl Med*. [Basic Science / Preclinical]
Takigawa A (2026). [PMID: 41206092](https://pubmed.ncbi.nlm.nih.gov/41206092/). *Jpn J Clin Oncol*. [Clinical Trial Publication]
Limaiem F (2026). [PMID: 31082182](https://pubmed.ncbi.nlm.nih.gov/31082182/). *Unknown Journal*. [Review / Meta-Analysis]
Elwy AE (2026). [PMID: 41629256](https://pubmed.ncbi.nlm.nih.gov/41629256/). *Appl Immunohistochem Mol Morphol*. [Basic Science / Preclinical]
AI-curated news mentioning breast phyllodes tumor
Updated Apr 10, 2026
A recent study highlights the diagnostic challenges posed by primary inflammatory myofibroblastic tumors of the breast during aspiration cytology. This research underscores the need for heightened awareness among pathologists to avoid misdiagnosis.